The largest database of trusted experimental protocols

Whole genome sequencing data

Manufactured by Illumina

Whole-genome sequencing data provides a comprehensive analysis of an organism's complete genetic makeup. It encompasses the determination of the order of all the nucleotides (A, T, C, and G) present in the organism's DNA. This data can be utilized for various applications, including genetic research, disease diagnosis, and evolutionary studies.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using whole genome sequencing data

1

Benchmarking Tumor DNA Mixture Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Illumina whole genome sequencing data of four pairs of tumor and matched normal cell line samples were downloaded from The Cancer Genome Atlas (TCGA) (29 (link)) or Illumina BaseSpace (BaseSpace.illumina.com">https://BaseSpace.illumina.com). All of the 8 samples are at higher than 49x coverage, except for HCC2218BL at 37x (Table 1). Two independent normal 30X samples were also available for HCC1143 and HCC1954. For the other two samples HCC1187 and HCC2218, we generated a second ‘normal’ by downsampling the available matched normal to 30X. We will refer to these second normal samples as ‘0% mixtures’ as we will use them as a negative control to investigate whether methods detect tumor DNA in mixtures without tumor DNA.
By mixing the different amount of reads from pure tumor samples together with the ‘0% mixture’ samples (i.e. the second normal sample), a series of mixtures samples were created at 30x coverage with 5%, 20%, 40%, 60%, 80% and 95% of tumor DNA. These mixture samples were obtained as BAM files from TCGA (29 (link)) for HCC1143 and HCC1954, from Illumina BaseSpace for HCC1187 and HCC2218 (Supplementary Data). We also created an extra 10% mixture for all samples.
+ Open protocol
+ Expand
2

Transposition Events Linked to Resistance

Check if the same lab product or an alternative is used in the 5 most similar protocols
TE-tracker software was used to interrogate available Illumina whole-genome sequencing data from 122 epiRILs for the presence of >2 shared transposition evens (STEs) within the epiQTLs intervals (Gilly et al., 2014 (link)). STEs were analysed for statistically significant linkage with resistance phenotypes (RIs), using the same linear regression model as described above for DMR linkage analysis.
+ Open protocol
+ Expand
3

Genotyping and Recombination Profiling of F1 Offspring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sixty-three F1 offspring were reproduced from selfed R. breviuscula. Each F1 plant was sequenced with ~3× Illumina whole-genome sequencing data. To genotype F1 offspring, whole-genome sequencing Illumina sequences of each plant were first mapped to the rhyBreHap1 reference genome using bowtie2 (v.2.4.4) paired-end mode, and then SNPs were called by ‘bcftools mpileup’ and ‘bcftools call’ (v1.9) (with ––keep-alts, ––variants-only and ––multiallelic-caller flags enabled). Next, SNPs of each F1 sample were input to TIGER91 (link) for genotyping and to generate potential CO positions. In addition, RTIGER92 (link) was used to identify the genotypes of chromosomal segments by utilizing the corrected markers that resulted from TIGER. Only COs that agreed using both tools were kept. The recombination landscape from F1 COs (Supplementary Fig. 4) was plotted using the same strategy and sliding window, as illustrated for pollen nuclei.
+ Open protocol
+ Expand
4

Phased Genotype Evaluation Using Illumina and Nanopore

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the Illumina whole-genome sequencing data of Patient 1 and both its parents to obtain a high-confidence set of phased genotypes (including SNVs, short indels, and SVs), against which we subsequently evaluated the nanopore data analysis. We used GATK PhaseByTransmission (PBT)27 (link) to correct genotypes based on trio information and to obtain deterministic phasing for most loci. PBT settings were: “-prior 0.000001 -useAF GT -af_cap 0.0001”. The PBT-phased SNVs were used to evaluate the genome-wide read-backed phasing from nanopore data as well as for phasing the nanopore reads and the PBT-phased SVs were used to evaluate the nanopore read-backed phasing of the SVs (i.e., evaluation was limited to the SVs detected in both nanopore and Illumina data). PBT was run with a de novo mutation prior of 10e-6 and supplied with the population allele frequencies of 1KG phase 3 European population.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!